H. R. Bu?ller, G. Agnelli, and R. Hull, Antithrombotic Therapy for Venous Thromboembolic Disease. The Seventh ACCP Conference on antithrombotic and thrombolytic therapy, Chest, vol.126, pp.401-428, 2004.

C. Kearon, E. A. Akl, J. Ornelas, A. Blaivas, D. Jimenez et al.,

, Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report, Chest, vol.149, pp.315-352, 2016.

C. Kearon and E. A. Akl, Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism, Blood, vol.123, pp.1794-1801, 2014.

C. Kearon, S. R. Kahn, G. Agnelli, S. Goldhaber, G. E. Raskob et al., Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, vol.133, pp.454-545, 2008.

J. Fahrni, M. Husmann, S. B. Gretener, and H. H. Keo, Assessing the Risk of Recurrent Venous Thromboembolism -a Practical Approach, Vascular Health Risk Management, vol.11, pp.451-459, 2015.

S. V. Konstantinides, A. Torbicki, G. Agnelli, N. Danchin, D. Fitzmaurice et al., Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism, Eur Heart J, vol.35, issue.43, pp.3033-69, 2014.

F. Couturaud, O. Sanchez, G. Pernod, P. Mismetti, P. Jego et al.,

C. B. Sollier, E. Presles, P. Castellant, F. Parent, P. Y. Salaun et al., Mottier D; PADIS-PE trial investigators. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial, JAMA, vol.314, issue.1, pp.31-40, 2015.

C. Kearon, E. A. Akl, J. Ornelas, A. Blaivas, D. Jimenez et al.,

, Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report, Chest, vol.149, pp.315-352, 2016.

C. Kearon and E. A. Akl, Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism, Blood, vol.123, pp.1794-1801, 2014.

P. Prandoni, F. Noventa, A. Ghirarduzzi, V. Pengo, E. Bernardi et al., The Risk of Recurrent Venous Thromboembolism After Discontinuing Anticoagulation In Patients With Acute Proximal Deep Vein Thrombosis Or Pulmonary Embolism. A Prospective Cohort Study In 1,626 Patients. Haematologica, pp.199-205, 2007.

L. Linkins, P. T. Choi, and J. D. Douketis, Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis, Ann Intern Med, vol.139, pp.893-900, 2003.

S. Schulman, R. J. Beyth, C. Kearon, and M. N. Levine, Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, vol.133, pp.257-298, 2008.

A. Rubboli, C. Becattini, and F. Verheugt, Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy, World Journal of Cardiology, vol.3, issue.11, pp.351-358, 2011.

M. A. Rodger, S. R. Kahn, P. S. Wells, A. D. Chagnon, I. et al., Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy, Canadian Medical Association Journal, vol.179, issue.5, pp.417-426, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00685547

A. Tosetto, A. Iorio, and M. Marcucci, Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH), J Thromb Haemost, vol.10, pp.1019-1044, 2012.

S. Eichinger, G. Heinze, and L. M. Jandeck, Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model, Circulation, vol.121, pp.1630-1636, 2010.

R. Lecumberri, A. Alfonso, D. Jiménez, F. Capitán, C. Prandoni et al., Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism, Thromb Haemost, vol.110, issue.04, pp.834-843, 2013.

J. D. Douketis, C. S. Gu, S. Shulman, A. Ghirarduzzi, V. Pengo et al., The Risk for Fatal Pulmonary Embolism After Discontinuing Anticoagulant Therapy for Venous Thromboembolism, Annals of Internal Medicine, vol.147, pp.766-774

C. Tromeur, O. Sanchez, E. Presles, D. Pernod, L. Bertoletti et al.,

S. Laporte, G. Meyer, D. Mottier, C. Leroyer, and F. Couturaud, Risk Factors of Residual Pulmonary Vascular Obstruction After Unprovoked Pulmonary Embolism, European Respiratory Journal, vol.51, issue.1, p.1701202, 2018.

B. Planquette, A. Ferré, and J. Péron, Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study, Thromb Res, vol.148, pp.70-75, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02057792

R. Pesavento, L. Filippi, and A. Palla, Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism, Eur Respir J, vol.49, p.1601980, 2017.

M. Miniati, S. Monti, and M. Bottai, Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism, Medicine, vol.85, pp.253-262, 2006.

C. Becattini, M. Guistozzi, P. Cerda, L. Cimini, A. Riera-mestre et al., Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis, J Thromb Haemost, vol.17, pp.1217-1228, 2019.

V. F. Tapson, Acute pulmonary embolism, N Engl J Med, vol.358, issue.10, pp.1037-1052, 2008.

C. Kearon, J. A. Julian, T. E. Newman, and J. S. Ginsberg, McMaster Diagnostic Imaging Practice Guidelines Initiative, Ann Intern Med, vol.128, issue.8, p.425, 1998.

G. Meyer, M. A. Collignon, F. Guinet, A. A. Jeffrey, L. Barritault et al., Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism, Eur J Nucl Med, vol.17, pp.315-334, 1990.

S. D. Quanadli, E. Hajjam, M. Vieillard-baron, A. Joseph, T. Mesurolle et al., New CT Index to Quantify Arterial Obstruction in Pulmonary Embolism-Comparison with Angiographic Index and Echocardiography

, American Journal of Roentgenology, vol.176, issue.6, pp.1415-1420, 2001.

N. Meneveau, O. Ider, M. Seronde, R. Chopard, S. Davani et al., Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate-to high-risk pulmonary embolism, European Heart Journal, vol.34, pp.693-701, 2013.

T. Wan, M. Rodger, W. Zeng, P. Robin, M. Righini et al., Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study, Thrombosis Research, vol.162, pp.104-109, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02059245

J. F. Timp, S. K. Braekkan, and W. M. Lijfering, Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP), PLoS Med, vol.16, issue.10, p.1002883, 2019.